This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Glossary
The glossary explains some of the words used across this website and covers some key cancer and research terms, which primarily focus on lung cancer.
Genomic profiling
A type of precision medicine that uses the genetic profile of a tumour to assess cancer subtype and classification, allowing for more targeted and effective treatments.1 See also ‘precision medicine’
Guideline-concordant care
Care that provides patients with the minimal treatment as defined by national guidelines.2 See also ‘guidelines’
Guidelines
Accredited organisations often publish best-practice guidelines that healthcare professionals may refer to when set-up of an intervention. These tend to be a robust, evidence-based and a formally agreed upon set of recommended criteria, protocols or classification systems for the clinical management of a disease.3
See also ‘Incidental nodule management protocol’
References
Chakravarty D, Solit DB. 2021. Clinical cancer genomic profiling. Nature Reviews Genetics 22(8): 483-501
Blom EF, Ten Haaf K, Arenberg DA, et al. 2020. Disparities in Receiving Guideline-Concordant Treatment for Lung Cancer in the United States. Annals of the American Thoracic Society 17(2): 186-94
National Comprehensive Cancer Network. 2022. NCCN Clinical Practice Guidelines in Oncology; Lung cancer screening: v1.2022 – October 26, 2021. Plymouth, PA: NCCN